Himalaya Technologies, Inc. announced that on June 1, 2022, it signed a co-pack agreement to create 500 cases of FOMO CAN with 24 units per case with a manufacturer in the Midwest. Costs include $50,000 for formulation of the product due to minority investment GenBio Inc. and $20,000 for manufacturing due to the supplier. A trial run is contemplated with channel partners of the manufacturer, which makes and sells sodas and adult beverages in 32 states.

The product is intended to provide anti-inflammatory and anti-blood pressure benefits and is anticipated to be a revolutionary health drink with no caffeine. The brand FOMO" has been trademarked in the USA by affiliate FOMO CORP.